GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS

In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus. Dans un mode de réalisation, la présente invention concerne un composé de formule, ou un sel pharmaceu...

Full description

Saved in:
Bibliographic Details
Main Authors BUCHANAN, Travis Lamonte, HERGUETA, Antonio Rodriguez, WOERLY, Eric Michael, CUMMING, Graham Robert, CHEN, Qi, BAUER, Renato Alejandro
Format Patent
LanguageEnglish
French
Published 16.05.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus. Dans un mode de réalisation, la présente invention concerne un composé de formule, ou un sel pharmaceutiquement acceptable de celui-ci, et des procédés d'utilisation de ce composé dans le traitement du diabète sucré de type II.
Bibliography:Application Number: WO2023US78764